Introduction
============

Clinically speaking, nasopharyngeal cancer (NPC) is one of the most deceptive cancers[@b1-cment-4-2011-005] and it has a complex interaction between genetic, environmental, dietary and viral factors in its etiology.[@b2-cment-4-2011-005],[@b3-cment-4-2011-005] This makes it one of the most challenging diseases to clinicians and researchers.

Genetic susceptibility is proposed as a risk factor for the development of nasopharyngeal cancer. Certain haplotypes of human leukocyte antigens (HLA) are associated with NPC; these include: HLA-A2, HLA-B46 and HLA-B58.[@b4-cment-4-2011-005],[@b5-cment-4-2011-005]

Nasopharyngeal cancer has a distinct racial distribution in countries with multiracial populations; this has been reported in high risk countries like China,[@b6-cment-4-2011-005] and intermediate risk countries like Malaysia[@b6-cment-4-2011-005],[@b7-cment-4-2011-005] and Sudan.[@b8-cment-4-2011-005] Even the low risk countries like North America and Britain are not exempt from this distinct ethnic predilection.[@b9-cment-4-2011-005] The racial distribution and the fact that certain haplotypes are associated with this malignancy support genetic susceptibility to this cancer.

The link between NPC and Epstein-Barr virus (EBV) is well established, as the sera of patients with this malignancy were found to contain precipitating antibodies against the virus;[@b10-cment-4-2011-005] the virus genome was also detected in biopsy material from most NPC patients.[@b11-cment-4-2011-005]

Environmental factors also play a role in the etiology of this disease, which is evident from the remarkable geographical distribution seen even in countries inhabited by a single ethnic group such as China.[@b12-cment-4-2011-005]

NPC forms around 6% of all cancer cases in the Sudan Cancer Registry (SCR) records, and 7% at the Radiation Isotope Center---Khartoum (RICK). Although Sudan is categorized as an intermediate risk country, there have been only two reports since 1983.[@b8-cment-4-2011-005],[@b13-cment-4-2011-005]

This paper describes the epidemiology, clinical manifestations and tribal distribution of NPC in Sudan. It shows that the disease is more common in certain tribes in the country and that patients report in advanced stages of the disease.

Objectives
==========

To study the epidemiology, clinical features, staging, possible etiology and pathology of nasopharyngeal cancer (NPC) in Sudan.

Materials and Methods
=====================

Cases of biopsy-proven NPC, who attended the Ear, Nose and Throat (ENT) Department of the Khartoum Teaching Hospital between March 2004 and May 2010, were investigated.

The ENT department of Khartoum Hospital is the national center for ENT diseases. Data collected on all patients included: age, gender, self-reported ethnic group, residence, nutritional habits, smoking and alcohol use as well as clinical data, pathology results and staging according to the AJCC/UICC 2002 system.[@b14-cment-4-2011-005]

Patients were assessed clinically; where nasopharyngoscopy was performed, nasopharyngeal specimens were taken for histological examination. Evaluation of locoregional extension was assessed by MRI and/or CT scan. Patients with histologically proven NPC, who signed an informed consent form, were included in the study; patients with incomplete clinical data were not included. Patients that were diagnosed with nasopharyngeal lymphoma were excluded.

Confirmed cases of NPC were sent to RICK for management.

Data was analyzed using SPSS version 15. Statistical significance was determined by the two-tailed *P*-value using Fisher's test.

This research was approved and ethically cleared by the Ethical Committee Board of the Institute of Endemic Diseases, University of Khartoum in March 2005.

Results
=======

The total number of NPC patients was 385. The age distribution showed two peaks: one at 15--19 years and the other at 50--54 years, as shown in [Figure 1](#f1-cment-4-2011-005){ref-type="fig"}. The male-to-female ratio was 2.6:1.

The geographical location of patients according to their origin is shown in [Figure 2](#f2-cment-4-2011-005){ref-type="fig"}. Western states showed the highest percentage, accounting for 36.62% of all cases; 75% of these were from Kurdufan state and 25% were from Darfur state. On the other hand, the distribution of cases from other states is equivalent to or less than expected according to population density, as shown in [Table 1](#t1-cment-4-2011-005){ref-type="table"}.

Detailed distribution of patients in the western part of the country showed clustering of patients in the Kadugli and Dilling areas of the Nuba Mountains, as shown in [Figure 3](#f3-cment-4-2011-005){ref-type="fig"}.

The Nuba tribe accounted for 17.1% of cases, a significantly higher percentage than expected (see [Table 2](#t2-cment-4-2011-005){ref-type="table"}), followed by the Denka tribe (12.98%) and the Galien tribe (9%). Both the Gawama'h and Messairy tribes accounted for 3.9%; other tribes showed nearly even distribution.

The mean age of Nuba patients was 39 years and that of non-Nuba patients was 41 years. The *P*-value was less than 0.0001, stating no significant statistical difference.

Smoking and alcohol consumption were found to be well correlated with NPC when data from this series were compared to a similar number of non-NPC patients attending the ENT hospital at the time of the study. On the other hand, lifestyle factors such as nutrition and cooking habits showed no correlation with NPC in our series.

Symptoms and signs at presentation, in order of frequency, were audiological in 89% of patients, followed by cervical lymphadenopathy in 78% and nasal symptoms in 69.7%. Cranial nerve involvement was present in a considerable number of patients, as it occurred in 39.3% of patients. Some effects of cranial nerve involvement are illustrated in [Figures 4](#f4-cment-4-2011-005){ref-type="fig"}, [5](#f5-cment-4-2011-005){ref-type="fig"} and [6](#f6-cment-4-2011-005){ref-type="fig"}.

Patients were classified at presentation according to the AJCC/UICC 2002 system[@b14-cment-4-2011-005] as shown in [Table 3](#t3-cment-4-2011-005){ref-type="table"}. Nearly 68% of cases were classified as stage IV disease.

In all cases, biopsies were taken from the nasopharynx under local anesthesia; it was conclusive in 97.4% of cases. The remaining 2.6% were re-biopsied under general anesthesia to reach a firm diagnosis.

The World Health Organization (WHO) histological classification of nasopharyngeal specimens is shown in [Table 4](#t4-cment-4-2011-005){ref-type="table"}. Types II and III, and mixed II and III accounted for 96.87%, whereas Type I was identified in only 1.18%.

Patients were followed up during treatment and three monthly thereafter. The initial response to treatment was excellent with regard to local control; details of outcome in terms of disease-free survival rates and residual disease are to be reported elsewhere.

Discussion
==========

Sudan is a country with more than 15 main ethnic groups.[@b15-cment-4-2011-005] There is a clear tribal pattern of the disease in our study, where 17.1% of patients belong to the Nuba tribe, which is statistically significant. Nuba people are distributed in all states of Sudan; less than half of them, according to local reports, inhabit the Nuba mountains area. This is similar to the tribal pattern of NPC in a study conducted by Hidayatalla et al in 1983;[@b8-cment-4-2011-005] however, the remaining tribal distribution of Hidayatalla et al's study is different from that of ours. We observed that the Denka tribe, the biggest southern tribe, was second to Nuba in the prevalence of NPC.

The age distribution of our studied patients showed two peaks, in a manner resembling that of intermediate risk countries and different from that observed in endemic areas.[@b16-cment-4-2011-005] One peak was observed in the 15--19 year age group and the other peak was in the 50--54 year age group. The early peak and distinct tribal distribution reflect a genetic susceptibility, which necessitates further detailed investigations such as HLA typing to identify high risk populations.

Geological studies showed that radiation exposure rates around the Nuba Mountains are among the highest in the world in regard to background radiation. Radiation exposure in the Nuba Mountains is mainly due to uranium, a byproduct of usable rock phosphate fertilizers.[@b17-cment-4-2011-005],[@b18-cment-4-2011-005] On one hand, the use of ground rock phosphate as fertilizers by local farmers would lead to direct external radiation exposure by handling and storage; on the other hand, inhalation of rock phosphate dust may increase internal exposure considerably. This could explain the clustering of patients around the Nuba Mountains area.

Recent studies showed that certain crops showed an increased accumulation of some metals that are contained in the soil, including radioactive substances.[@b19-cment-4-2011-005] Drinking water in the Nuba Mountains area, which is also used for irrigation of crops, could be contaminated with radioactive uranium and crops could accumulate radioactive metals. Studies are needed to verify this and its impact on health.

Histological classification of the samples resembles that of endemic areas, with a predominance of Types III and II. According to previous studies, these types are associated with high rates of EBV detection.[@b20-cment-4-2011-005]

The use of endoscopy has enabled accurate visualization of the nasopharynx and precise biopsy, as it is capable of diagnosing 97.4% of patients. Biopsy under local anesthesia is cost-effective in terms of hospital admission and it avoids the hazards of general anesthesia.

Unfortunately, about 68% of the cases were diagnosed at stage IV, which is a significantly high percentage of late presentation. Is it possible that this is due to difficulty in accessing the health care system and/or lack of patient knowledge about worrisome symptoms that might signal NPC.

Since prognosis is well correlated to the stage of presentation, conducting screening programs for at-risk populations could help in earlier diagnosis and probably a better prognosis.

Conclusions
===========

Nasopharyngeal cancer in Sudan has a distinct tribal and geographic pattern. The age distribution of NPC has two peaks, an early peak and a late one. The tribal tendency of the disease and an early peak support a genetic predisposition; HLA typing is required in future studies. The second peak, histology and geographic distribution support the role of environmental factors.

Setting up screening programs for early diagnosis and management of NPC in high risk populations such as the Nuba tribe are advocated. Further studies are strongly needed to identify environmental factors that are involved in the etiology of NPC in Sudan, including radiation levels in drinking water and crops at Nuba mountains area.

The Academy of Sciences for the Developing World funded the expenses of this research. Histological study of nasopharyngeal specimens was done by El-Zahrawi Medical Laboratory staff. Medical staff of the ENT Department of Khartoum Teaching Hospital and RICK contributed to the management of NPC patients.
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![Age distribution in years of studied patients. A bimodal pattern is observed, with an early peak at the 15--19 years and a later peak at 50--54 years.](cment-4-2011-005f1){#f1-cment-4-2011-005}

![Distribution of NPC patients in different states of Sudan. Patients were evenly distributed according to population density except for the Western States, where a higher number than expected is reported. (*P*-value = 0.00004836).](cment-4-2011-005f2){#f2-cment-4-2011-005}

![The distribution of patients in western Sudan according to their origin; mean residence is 27 years. The total number of patients distributed in western states is 141, which accounts for 36.62% of all patients.\
**Notes:** Each square represents three cases.\
1. Kutum, 2. Hamrrat Esheikh, 3. Um Sayala, 4. Geneina, 5. Zalinje, 6. Fashir, 7. Bara, 8. El Obeid, 9. Um Ruwaba, 10. Nyala, 11. En Nahud, 12. Abu Zabad, 13. Dilling, 14. Nuba Mountains, 15. Buram, 16. De'en 17. Babanusa, 18. El Fula, 19. Kadugli, 20. Abu Gubeiha, 21. El Muglad.](cment-4-2011-005f3){#f3-cment-4-2011-005}

![Multiple cervical lymphadenopathy, showing levels 2, 3, 4 and 5; note skin tethering.](cment-4-2011-005f4){#f4-cment-4-2011-005}

![Complete ophthalmoplegia of the right eye in a patient presenting with ipsilateral nasopharyngeal mass but no palpable cervical lymph nodes.](cment-4-2011-005f5){#f5-cment-4-2011-005}

![Cranial nerve involvement raises the stage to T4. Note the deviation of the tongue, which signifies hypoglossal nerve involvement.](cment-4-2011-005f6){#f6-cment-4-2011-005}

###### 

Geographical distribution of NPC patients in Sudan, compared to geographical distribution of the general population. *P*-value is calculated using Fisher's exact test.

  **Region**                                **Expected percentage**   **Observed percentage**   **Population of the region (N)**   **Expected cases (N)**   **Observed cases in the study (N)**   ***P*-value (two-tailed)**
  ----------------------------------------- ------------------------- ------------------------- ---------------------------------- ------------------------ ------------------------------------- ----------------------------
  West                                      23.07%                    36.62%                    9,000,000                          88                       141                                   \<0.0001
  East                                      10.24%                    5.71%                     4,000,000                          39                       22                                    0.032
  North                                     1.53%                     3.11%                     600                                0                        12                                    0.0004
  South                                     20.50%                    12.46%                    8,000,000                          77                       48                                    0.0061
  Khartoum                                  15.38%                    17.40%                    6,000,000                          57                       67                                    0.03776
  Central Provinces (apart from Khartoum)   23.22%                    22.07%                    12,000,000                         89                       85                                    0.7961
  Total                                     100                       100                       39,600,000                                                  385                                   

###### 

Tribal distribution of studied patients (only the three commonest tribes are listed). The percentage of a specific tribe's distribution in relation to the general population is obtained from local reports. *P*-value is calculated using Fisher's exact test.

  **Tribe**   **Percentage in general sudanese population**   **Percentage in the study**   **Actual No.**   **Expected No.**   ***P*-value (two-tailed)**
  ----------- ----------------------------------------------- ----------------------------- ---------------- ------------------ ----------------------------
  Nuba        6%                                              17.10%                        66               23.1               \<0.0001
  Dinka       8%                                              12.98%                        50               30.8               0.078
  Gaaliin     6.25%                                           9%                            34               24.06              0.2188

###### 

Stage classification of the study population, according to the AJCC/UICC system.[@b14-cment-4-2011-005]

  **Stage classification**   **No. of cases**   **Percentage**
  -------------------------- ------------------ ----------------
  Stage I                    11                 2.85
  Stage IIa                  17                 4.4
  Stage IIb                  29                 7.53
  Stage III                  60                 15.58
  Stage IVa                  96                 24.93
  Stage IVb                  166                43.11
  Stage IVc                  6                  0.015
  Total                      385                100

###### 

Histopathology of nasopharyngeal tissue biopsy, according to the WHO classification.

  **Histology Type**      **N**   **Percentage**
  ----------------------- ------- ----------------
  Type I                  7       1.81
  Type II                 60      15.58
  Type III                254     65.97
  Mixed type II & III     56      14.54
  Mixed type I & III      3       0.78
  Salivary gland origin   2       0.51
  Others                  3       0.78
  Total                   385     100
